RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment

• Asıl Yazarlar: Feifei Li (Yazar), Hang Gong (Yazar), Xinfei Jia (Yazar), Chang Gao (Yazar), Peng Jia (Yazar), Xin Zhao (Yazar), Wenxia Chen (Yazar), Lili Wang (Yazar), Nina Xue (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2024-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

<b>Background and objective</b>: Cannabinoids are commonly used as adjuvant cancer drugs to overcome numerous adverse side effects for patients. The aim of this study was to identify the target genes that show a synergistic anti-tumor role in combination with the cannabinoid WIN55212-2 i...